ID   VACO 330
AC   CVCL_5399
SY   VACO330; VACO-330; V330
DR   cancercelllines; CVCL_5399
DR   IARC_TP53; 217
DR   Wikidata; Q54992707
RX   PubMed=2253215;
RX   PubMed=3567899;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=2253215).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=2253215;
RA   Baker S.J., Preisinger A.C., Jessup J.M., Paraskeva C., Markowitz S.D.,
RA   Willson J.K.V., Hamilton S.R., Vogelstein B.;
RT   "p53 gene mutations occur in combination with 17p allelic deletions as
RT   late events in colorectal tumorigenesis.";
RL   Cancer Res. 50:7717-7722(1990).
//
RX   PubMed=3567899;
RA   Willson J.K.V., Bittner G.N., Oberley T.D., Meisner L.F., Weese J.L.;
RT   "Cell culture of human colon adenomas and carcinomas.";
RL   Cancer Res. 47:2704-2713(1987).
//